Anti-anxiety medications for dogs and cats have evolved significantly, with licensed veterinary products now available for specific conditions. Used appropriately alongside behaviour modification, pharmacological support is a welfare-positive intervention for animals in chronic distress.
The use of anti-anxiety medication in companion animals reflects a mature understanding that chronic anxiety is a welfare problem, not a training failure to be resolved through discipline. A dog with severe separation anxiety or a cat with chronic fear-based aggression is experiencing genuine suffering that behaviour modification alone may not reach if arousal levels remain too high for learning to occur. Licensed veterinary medications lower the physiological substrate of anxiety sufficiently to make behaviour therapy possible, creating a synergistic treatment where neither pharmacology nor behaviour modification alone would succeed. Reluctance to consider medication — often based on the misperception that it constitutes sedation or weakness — delays relief from suffering for animals whose welfare depends on appropriate multi-modal treatment. The welfare-consistent position is to evaluate anxiety medications as seriously as any other treatment for a condition causing chronic suffering.